Cancel
Chief Marketing and Strategy Officer - Paul Verrastro
Paul Verrastro holds the position of Chief Marketing and Strategy Officer. He possesses over 33 years of experience in the cardiac rhythm market, contributing his expertise to multiple leading companies in the industry. In his current role, he oversees marketing strategies and strategic direction, leveraging his extensive background to drive growth and innovation within the organization.
Paul Verrastro's Educational Background
Paul Verrastro earned his Bachelor of Science degree from Syracuse University, establishing a strong foundation for his career in the marketing and cardiac rhythm sectors. His formal education has supported his subsequent roles and responsibilities, allowing him to excel in a highly specialized field.
Paul Verrastro's Industry Background and Experience
Paul Verrastro has a robust background in the cardiac rhythm market, beginning his career as a sales representative for Medtronic. He has held significant roles including Director of Implantable Cardiac Defibrillators Marketing at Guidant Corporation and Vice President of Marketing for Guidant Corporation in Europe. His experience also extends to serving as Vice President of Global Marketing for Guidant Corporation's customer relationship management division and rejoining Medtronic as Vice President of Global Strategic Marketing in May 2011.
Consulting Work by Paul Verrastro
Paul Verrastro managed his own consulting business, offering his expertise to high-profile clients such as St. Jude Medical, Abbott Cardiovascular, and Medtronic CRDM. Through his consultancy, Paul provided strategic guidance and marketing insights to instrumental organizations, further solidifying his influence in the cardiac rhythm industry.
Technologies Marketed by Paul Verrastro
Throughout his career, Paul Verrastro has played a pivotal role in bringing innovative technologies to market. His contributions include the introduction of implantable cardiac defibrillators, cardiac resynchronization therapies, implantable loop recorders, and leadless pacing. These advancements have had a significant impact on the cardiac rhythm market, demonstrating Paul's capacity to drive technological progress.
